| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT07499232 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely… |
Trial sites expanded: 11 -> 30 locations |
| 2026-05-29 | NCT06548542 Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to… |
Primary endpoint(s) modified |
| 2026-05-29 | NCT06548542 Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to… |
date change Primary completion pushed: 2027-12 -> 2030-01 |
| 2026-05-29 | NCT06548542 Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to… |
date change Completion pushed: 2028-08 -> 2030-01 |
| 2026-05-29 | NCT06880744 A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-29 | NCT06880744 A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to… |
date change Primary completion moved earlier: 2028-09 -> 2027-08 |
| 2026-05-14 | NCT07071519 A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative… |
Trial sites expanded: 40 -> 45 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07352566 | Utilization of a Microdevice for Psoriasis and Atopic Dermatitis | Psoriasis | Not Yet Recruiting |
| Phase 3 | |||
| NCT06100744 | A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves… | Juvenile Psoriatic Arthritis | Recruiting |
| NCT06641089 | Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα… | Arthritis, Psoriatic | Recruiting |
| NCT05995353 | A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and… | Crohn's Disease | Recruiting |
| NCT07071519 | A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative… | Ulcerative Colitis | Recruiting |
| NCT07499232 | A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely… | Crohn Disease | Recruiting |
| NCT03398135 | A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative… | Ulcerative Colitis (UC) | Active, Not Recruiting |
| NCT04524611 | Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to… | Crohn's Disease (CD) | Active, Not Recruiting |
| NCT06880744 | A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to… | Ulcerative Colitis | Active, Not Recruiting |
| NCT06624228 | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants… | Psoriatic Arthritis | Active, Not Recruiting |
| Phase 2 | |||
| NCT06548542 | Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to… | Crohn's Disease | Recruiting |
| Phase 1 | |||
| NCT07466550 | A Study to Assess How Intravenous and Subcutaneous Administrations of Risankizumab Moves… | Healthy Volunteer | Not Yet Recruiting |
| Not specified | |||
| NCT06249555 | VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's… | Crohn's Disease | Recruiting |
| NCT07448402 | Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease | Psoriasis | Not Yet Recruiting |